CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 691905-692157 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T47269","span":{"begin":0,"end":252},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1405","span":{"begin":0,"end":252},"obj":"Epistemic_statement"}],"text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T202","span":{"begin":0,"end":252},"obj":"Sentence"}],"text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1292","span":{"begin":16,"end":43},"obj":"Phenotype"}],"attributes":[{"id":"A1292","pred":"hp_id","subj":"T1292","obj":"http://purl.obolibrary.org/obo/HP_0003613"}],"text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2249","span":{"begin":204,"end":226},"obj":"Body_part"},{"id":"T2250","span":{"begin":212,"end":226},"obj":"Body_part"}],"attributes":[{"id":"A2249","pred":"uberon_id","subj":"T2249","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A2250","pred":"uberon_id","subj":"T2250","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"}],"text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4225","span":{"begin":51,"end":76},"obj":"Disease"},{"id":"T4226","span":{"begin":143,"end":163},"obj":"Disease"},{"id":"T96674","span":{"begin":51,"end":76},"obj":"Disease"},{"id":"T12457","span":{"begin":143,"end":163},"obj":"Disease"}],"attributes":[{"id":"A4225","pred":"mondo_id","subj":"T4225","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"},{"id":"A4226","pred":"mondo_id","subj":"T4226","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A44479","pred":"mondo_id","subj":"T96674","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"},{"id":"A28592","pred":"mondo_id","subj":"T12457","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"}],"text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events."}